CytomX Therapeutics Announces Full-Year 2018 Financial Results

NEXT STORY
FibroGen Reports Fourth Quarter and Full Year 2018 Financial Results
PREV STORY
Sarepta Therapeutics Announces Fourth Quarter 2018 and Full-Year 2018 Financial Results and Recent Corporate Developments
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Checkpoint Therapeutics to Participate in Two Upcoming Investor Conferences

author_avatar
NASDAQ Market News

Merit Medical Systems to Announce First Quarter Results on April 23, 2019

author_avatar
NASDAQ Market News

Galera Announces Updated Data from its Randomized, Multicenter, Placebo-Controlled Trial in Patients with Pancreatic Cancer

author_avatar
NASDAQ Market News